Your browser doesn't support javascript.
loading
Determining Cost-Optimal Next-Generation Sequencing Panels for Rare Disease and Pharmacogenomics Testing.
Katragadda, Shanmukh; Hall, Taryn O; Bettadapura, Radhakrishna; Dalton, Joline C; Ganapathy, Aparna; Ghana, Pallavi; Hariharan, Ramesh; Janakiraman, Anand; Kotha, Kumar B V S S P; Manjunath, Ashwini; Mannan, Ashraf U; Ms, Niveditha; Saraf, Shradha; Tzeng, Kathy T H; Veeramachaneni, Vamsi.
  • Katragadda S; Strand Life Sciences, Bengaluru, India.
  • Hall TO; OptumLabs, Minnetonka, MN,USA.
  • Bettadapura R; Strand Life Sciences, Bengaluru, India.
  • Dalton JC; OptumLabs, Minnetonka, MN,USA.
  • Ganapathy A; Strand Life Sciences, Bengaluru, India.
  • Ghana P; Strand Life Sciences, Bengaluru, India.
  • Hariharan R; Strand Life Sciences, Bengaluru, India.
  • Janakiraman A; Strand Life Sciences, Bengaluru, India.
  • Kotha KBVSSP; Strand Life Sciences, Bengaluru, India.
  • Manjunath A; Strand Life Sciences, Bengaluru, India.
  • Mannan AU; Strand Life Sciences, Bengaluru, India.
  • Ms N; Strand Life Sciences, Bengaluru, India.
  • Saraf S; Strand Life Sciences, Bengaluru, India.
  • Tzeng KTH; OptumLabs, Minnetonka, MN,USA.
  • Veeramachaneni V; Strand Life Sciences, Bengaluru, India.
Clin Chem ; 67(8): 1122-1132, 2021 08 05.
Article en En | MEDLINE | ID: mdl-34120169

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Farmacogenética / Enfermedades Raras Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Farmacogenética / Enfermedades Raras Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article